Background: Cervical cancer screening has shifted toward human papillomavirus (HPV)-
based testing, but uptake of primary HPV screening in the United States is unknown and …

Background: Evidence-based guidelines have been created by professional societies,
including the United States Preventive Services Task Force (USPSTF) and American Society …

Objectives Primary human papillomavirus (HPV) testing by clinician-collection is endorsed
by US guideline organizations for cervical cancer screening, but uptake remains low and …

Abstract In 2018, the US Preventive Services Task Force endorsed primary human
papillomavirus testing (pHPV) for cervical cancer screening. We aimed to describe …

Background: Current clinical guidelines recommended primary human papillomavirus (HPV)
screening for cervical cancer testing. Previous studies reported patient-level barriers (eg …

Background: Adjunct human papillomavirus (HPV) testing with cervical cytology (Pap test) is
one option that can increase screening intervals for women aged≥ 30 years who have …

Background Primary HPV testing (without the Pap test) has recently been recommended as
a cervical cancer screening option in the United States. US women's awareness and …

Background: Guidelines for cervical cancer screening have been updated to include human
papillomavirus (HPV) testing, which is more sensitive compared to cytology in detecting …

Background The human papillomavirus (HPV) test, administered alone without the
Papanicolaou (Pap) test, was recently recognized as a cervical cancer screening option in …

Abstract Background The 2020 American Cancer Society (ACS) guidelines are the most
recent national guidelines for cervical cancer screening. These guidelines propose two …